Navigation Links
China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination
Date:10/29/2008

China's SFDA Approves Entry into Clinical Trials on Schedule

HAIKOU CITY, China, Oct. 29 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, announced today that its novel antibiotic combination formula has been granted approval by China's State Food and Drug Administration (SFDA) to enter clinical trials.

The Company will initiate clinical trials in November 2008 to evaluate this drug, a third generation Cephalosporin antibiotic combined with a bacterial-enzyme inhibitor, for the treatment of infections. The development timeline is consistent with the company's predictions.

China Pharma's CEO and president, Ms Zhilin Li, commented, "We are pleased that the SFDA has approved our new antibiotic formula to enter clinical trials within our anticipated timeframe. We look forward to initiating and completing these clinical trials over the next two years and hope to confirm previous results that showed significant efficacy in clearing antibiotic resistant bacterial strains. Antibiotic resistance is a growing global problem that requires the development of more advanced treatment to effectively combat resistant strains. Pending successful clinical development, this therapy could capture market share in China from Cephalosporin antibiotics used to address various infections, including hospital-acquired and respiratory infections, bacterial meningitis, and pneumonia."

Microbial antibiotic resistance has emerged as a major public health problem in China and throughout the world. Many Cephalosporins marketed in China, including third generation Cephalosporins, have encountered bacterial resistance. Surveillance in China up to 2005 shows that 20% to 70% of certain target pathogen strains may be resistant to one or more third generation Cephalosporins.(*) Despite this drug resistance, Chin
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 29, 2015 , ... "I ... from Miller Place, N.Y. "I specialize in manual therapy, and my invention will ... can be used for additional muscle dysfunction throughout the body." , They developed ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... Next weekend ... of summer (which astronomically, officially ends on September 22nd this year). For IT security ... security hangovers linger on which could prove far more costly than a simple headache. ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health ... and sell Arterosil and Arterosil HP, and that all claims and counterclaims have ... Health Sciences, LLC (VHS) in the United States District Court for the Southern ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of ... for the position they are applying for, they are unable to pass the initial ... considering altering drug testing policies in order to be able to hire long-term, skilled ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a non-invasive ... two years, the longest of any cellulite reduction system currently on the market. ... solution for their cellulite, according to Dr. Robert Weiss, director of the premier MD ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... survey of businesses that looks at their preparations for ... Health (HSPH) researchers found that only one-third believe they ... half their workforce were absent for two weeks due ... believe they could avoid such problems for one month ...
... In a new report, University of Illinois professor Barbara H. Fiese ... promote family mealtimes as a matter of public policy. "There ... protecting their families as taking 18 to 20 minutes to eat ... week," said Fiese, a U of I professor of human development ...
... WASHINGTON, Sept. 9 The Henry M. Jackson Foundation ... Tug McGraw Foundation (TMF) and Grammy Award-winning country music stars Tim ... from the Frontlines to the Homefront ." The presenting sponsor of ... Country United is a two-day event dedicated to supporting ...
... , BOSTON, Sept. 9 A recent study ... of laboratory use and confinement. Developmental Context Effects on ... the September issue, Vol. 45 (5), of the American Psychological ... , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090909/DC72238 ) , ...
... , , , ... the global anti-aging skincare market approached $15 billion(1), with 32 ... many over-the-counter products are claiming to achieve comparable benefits as ... to grow, but FDA-approved prescription products with rigorous efficacy and ...
... Workforce Prescriptions ("WRX") announced on Tuesday the launch of the Paradigm ... by a private endowment, developed to honor hospitals that have gone ... without resorting to workforce reductions or dramatic top-down mandates. , ... the paradigm shift in understanding required to see that the number ...
Cached Medicine News:Health News:Four-fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 2Health News:Four-fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 3Health News:Four-fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 4Health News:U of I acientist: Public policy should promote family mealtimes 2Health News:U of I acientist: Public policy should promote family mealtimes 3Health News:Tim McGraw and Faith Hill Lead Country United Effort to Benefit Military Medicine 2Health News:Tim McGraw and Faith Hill Lead Country United Effort to Benefit Military Medicine 3Health News:Chimpanzees Suffer Psychologically Like Humans 2Health News:Chimpanzees Suffer Psychologically Like Humans 3Health News:Leading Anti-Aging Prescription RENOVA(R) Continues To Deliver Maximum Results 2Health News:Leading Anti-Aging Prescription RENOVA(R) Continues To Deliver Maximum Results 3Health News:WRX Launches National Labor Efficiency Quality Award 2Health News:WRX Launches National Labor Efficiency Quality Award 3
(Date:8/28/2015)... SAN FRANCISCO, Calif. , Aug. 28, 2015 /PRNewswire/ ... for the treatment of cancer, today announced the filing ... U.S. Securities and Exchange Commission (SEC) relating to a ... number of shares to be offered and the price ... CytomX intends to list its common stock under the ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Developed by Roche under the trade name of ... the world. In Feb.26, 2010, it was approved by ... available in China all come ...
(Date:8/28/2015)... , Aug. 28, 2015  Today, in final ... (CDC) Contact Lens Health Week, 1-800 Contacts is sharing ... found that contact lens wearers who do not properly ... risk for eye infections. Most contact ... lenses, but a clean lens case is sometimes overlooked.  ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2
... WESTON, Fla., Jan. 14, 2011 American Scientific ... (Pink Sheets: ASFX ) wishes to announces that ... is available at www.sec.gov , has been declared effective ... Registration Statement means that the Company will commence reporting of ...
... Research Institute (IDRI) today announced it has received a ... Foundation for "Chemical genomics for the identification of targets ... is to identify new leads and new drug targets ... of producing new drugs to treat tuberculosis (TB). The ...
Cached Medicine Technology:American Scientific Resources, Inc. Announces S-1 Registration Statement Effective; Commences Public Reporting Requirements 2IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs 2
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 130o....
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 110o. Most popular size or model....
25 gauge cannula. 2 mm vertical spatula tip with opening on right side. 10 mm from tip to bend. Polished finish....
Angled blade and flat serrated handle with polished finish. Blade: 1 mm x 10 mm....
Medicine Products: